bluebird bio, Inc.
DelistedCIK 1293971fmd_15H3DN9C3GGSSG1TGDT1102JHHManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2011 to Mar 31, 2025, 54 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 14 | 6 | 35 | 55 | 0 | 0 | 4 | 4 | 29 | 84 |
| Cost of revenue | – | – | 2 | 1 | 3 | 5 | – | 10 | 34 | 89 |
| Gross profit | – | – | 34 | 54 | (3) | (5) | – | (6) | (4) | (6) |
| Research and development | 134 | 205 | 273 | 449 | 327 | 319 | 320 | 200 | 168 | 94 |
| Selling, general and administrative | – | – | 94 | 174 | 236 | 240 | 210 | 140 | 166 | 168 |
| Total operating expenses | 183 | 274 | 368 | 627 | – | – | – | – | – | – |
| Operating income | (169) | (268) | (332) | (572) | (563) | (559) | (591) | (250) | (244) | (270) |
| Interest expense | – | – | – | – | – | – | – | 6 | 16 | 23 |
| Interest and investment income | – | – | – | – | – | – | – | 1 | 10 | 8 |
| Other non-operating income (expense) | 2 | (0) | (1) | 2 | (10) | (7) | 28 | 25 | 39 | 44 |
| Income before taxes | (167) | (264) | (335) | (555) | (556) | (560) | (562) | (230) | (212) | (241) |
| Income tax expense | 0 | (1) | 0 | 0 | (1) | 1 | 0 | 0 | (0) | 0 |
| Net income from continuing operations | (167) | (264) | (336) | (556) | (555) | (561) | (563) | (267) | (212) | (241) |
| Net income | (167) | (264) | (336) | (556) | (790) | (619) | (819) | (230) | (212) | (241) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |